A Randomized Placebo-controlled Phase 2 Study of Decitabine With or Without Eltrombopag in AML Patients ≥65 Years of Age Not Eligible for Intensive Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 24 Jun 2017
At a glance
- Drugs Eltrombopag (Primary) ; Decitabine
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Acronyms DELTA
- 23 Jun 2017 Status changed from suspended to recruiting.
- 05 May 2017 Status changed to suspended.
- 05 Jan 2016 According to ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.